Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Norman N, Chan"'
Autor:
Norman N. Chan, Jenny Y. Y. Leung, Risa Ozaki, KK Lee, CH Choi, Grace Kam, Wing Sun Chow, Andrew Yiu Yan Ho, Kin-Wah Chan, June Li, Man-Wo Tsang, Kathryn C.B. Tan
Publikováno v:
Hong Kong Medical Journal. 25:312-319
Autor:
Vanessa W. S. Ng, Norman N. Chan, Wing-Yee So, Ronald C.W. Ma, Risa Ozaki, Chun-Chung Chow, Cheuk-Chun Szeto, Juliana C.N. Chan, Christopher W.K. Lam, Clive S. Cockram, Chung Shun Ho, Peter C.Y. Tong, Alice P.S. Kong
Publikováno v:
Diabetes Care. 29:2046-2052
OBJECTIVE—Chronic kidney disease (CKD) predicts cardiovascular disease (CVD) in the general population. We investigated the effects of stages of renal function using the estimated glomerular filtration rate (eGFR) on all-cause mortality and cardiov
Autor:
Peter C.Y. Tong, Norman N. Chan, Margaret H.L. Ng, Matthew K. W. Lo, W.B. Chan, Juliana C.N. Chan, Wing-Yee So, Ka-fai Lee
Publikováno v:
Diabetes Care. 27:216-222
OBJECTIVES—There are close associations among raised white blood cell (WBC) count, coronary heart disease, and metabolic syndrome in the general population. The association between WBC count and vascular complications of diabetes has not been explo
Autor:
Norman N. Chan, Gary T. C. Ko, K. W. Lo, W.B. Chan, C. C. Chow, June K. Y. Li, Michael H.M. Chan, Clive S. Cockram
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:581-587
The effect of biphosphonate therapy on bone mineral density (BMD) in patients with primary hyperparathyroidism (PHP) is unknown. Forty postmenopausal women (mean age, 70 yr) with PHP were randomized to receive alendronate 10 mg/d or placebo for 48 wk
Publikováno v:
Current diabetes reviews. 2(4)
Metabolic syndrome, also known as the insulin resistance syndrome (IRS), dysmetabolic syndrome or syndrome X, is a burgeoning global epidemic. This constellation of risk factors, namely glucose intolerance, hypertension, dyslipidemia (high triglyceri
Publikováno v:
Drug safety. 30(3)
Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the ren
Publikováno v:
The Clinical biochemist. Reviews. 26(3)
The Metabolic syndrome (MetS), obesity and type 2 diabetes are growing global epidemics especially in Asian populations. In light of the differences in body build between people from the West and the East, definitions of obesity in Asians have been m
Autor:
G. T. C. Ko, Risa Ozaki, Wing-Yee So, Chun-Chung Chow, Peter C.Y. Tong, W.B. Chan, C. S. Cockram, J K Y Li, Vincent T.F. Yeung, Juliana C.N. Chan, Norman N. Chan, Ronald C.W. Ma
Publikováno v:
Diabetes, obesitymetabolism. 8(1)
Aim: The aim of this study is to investigate the prevalence of metabolic syndrome (MES) in type 2 diabetic patients and the predictive values of the World Health Organization (WHO) and National Cholesterol Education Programme (NCEP) definitions and t
Autor:
Vincent T.F. Yeung, Risa Ozaki, Ronald C.W. Ma, Norman N. Chan, Wing-Yee So, Christopher W.K. Lam, Peter C.Y. Tong, Maggie C.Y. Ng, Emily Poon, Juliana C.N. Chan, Gary T.C. Ko, Chung-Shun Ho
Publikováno v:
The Journal of clinical endocrinology and metabolism. 90(12)
Context: Age-related declines in testosterone and IGF-I are associated with deposition of visceral fat, a component of the metabolic syndrome (MES). Objective: Testosterone and IGF-I may interact with familial disposition to diabetes mellitus to incr
Autor:
Chun-Chung Chow, Clive S. Cockram, W.B. Chan, Vincent T.F. Yeung, Wing-Yee So, Juliana Chun-Ngor Chan, Norman N. Chan, G. T. C. Ko
Publikováno v:
Diabetes research and clinical practice. 69(2)
The World Health Organisation (WHO), European Group for the Study of Insulin Resistance (EGIR) and National Cholesterol Education Program (NCEP) Expert Panels had introduced definitions for the metabolic syndrome (MES). We aimed to estimate the preva